Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank88
Studio
Year-over-Year Change

Free cash flow yield

Latest
-8.43%
↑ 40% vs avg
Percentile
P88
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-14.12%
Historical baseline
PeriodValueYoY Change
2025-8.43%-883.5%
2024-0.86%+96.1%
2023-22.10%+26.9%
2022-30.23%-135.8%
2021-12.82%+30.8%
2020-18.52%-73.2%
2019-10.70%+22.5%
2018-13.79%-43.5%
2017-9.61%-